Oral Therapy for Multiple Sclerosis - Sea Change or Incremental Step?

被引：17

作者：

Carroll, William M. ^{[1
]}

机构：

[1] Sir Charles Gairdner Hosp, Dept Neurol, Perth, WA 6000, Australia

来源：

NEW ENGLAND JOURNAL OF MEDICINE | 2010年 / 362卷 / 05期

关键词：

PLACEBO-CONTROLLED TRIAL; FINGOLIMOD; INTERFERON;

D O I：

10.1056/NEJMe0912019

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：456 / 458

页数：3

共 12 条

[1] Lessons from randomised direct comparative trials [J].

Achiron, Anat ;

Fredrikson, Sten .

JOURNAL OF THE NEUROLOGICAL SCIENCES, 2009, 277 :S19-S24

[2] Oral Fingolimod or Intramuscular Interferon for Relapsing Multiple Sclerosis [J].

Cohen, Jeffrey A. ;

Barkhof, Frederik ;

Comi, Giancarlo ;

Hartung, Hans-Peter ;

Khatri, Bhupendra O. ;

Montalban, Xavier ;

Pelletier, Jean ;

Capra, Ruggero ;

Gallo, Paolo ;

Izquierdo, Guillermo ;

Tiel-Wilck, Klaus ;

de Vera, Ana ;

Jin, James ;

Stites, Tracy ;

Wu, Stacy ;

Aradhye, Shreeram ;

Kappos, Ludwig .

NEW ENGLAND JOURNAL OF MEDICINE, 2010, 362 (05) :402-415

[3]

Coles AJ, 2008, NEW ENGL J MED, V359, P1786, DOI 10.1056/NEJMoa0802670

[4] INTERFERON BETA-1B IS EFFECTIVE IN RELAPSING-REMITTING MULTIPLE-SCLEROSIS - CLINICAL-RESULTS OF A MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED TRIAL [J].

DUQUETTE, P ;

GIRARD, M ;

DESPAULT, L ;

DUBOIS, R ;

KNOBLER, RL ;

LUBLIN, FD ;

KELLEY, L ;

FRANCIS, GS ;

LAPIERRE, Y ;

ANTEL, J ;

FREEDMAN, M ;

HUM, S ;

GREENSTEIN, JI ;

MISHRA, B ;

MULDOON, J ;

WHITAKER, JN ;

EVANS, BK ;

LAYTON, B ;

SIBLEY, WA ;

LAGUNA, J ;

KRIKAWA, J ;

PATY, DW ;

OGER, JJ ;

KASTRUKOFF, LF ;

MOORE, GRW ;

HASHIMOTO, SA ;

MORRISON, W ;

NELSON, J ;

GOODIN, DS ;

MASSA, SM ;

GUTTERIDGE, E ;

ARNASON, BGW ;

NORONHA, A ;

REDER, AT ;

MARTIA, R ;

EBERS, GC ;

RICE, GPA ;

LESAUX, J ;

JOHNSON, KP ;

PANITCH, HS ;

BEVER, CT ;

CONWAY, K ;

WALLENBERG, JC ;

BEDELL, L ;

VANDENNOORT, S ;

WEINSHENKER, B ;

WEISS, W ;

REINGOLD, S ;

PACHNER, A ;

TAYLOR, W .

NEUROLOGY, 1993, 43 (04) :655-661

[5] Every-other-day interferon beta-1b versus once-weekly interferon beta-1a for multiple sclerosis: results of a 2-year prospective randomised multicentre study (INCOMIN) [J].

Durelli, L ;

Verdun, E ;

Barbero, P ;

Bergui, M ;

Versino, E ;

Ghezzi, A ;

Montanari, E ;

Zaffaroni, M .

LANCET, 2002, 359 (9316) :1453-1460

[6] A Placebo-Controlled Trial of Oral Cladribine for Relapsing Multiple Sclerosis [J].

Giovannoni, Gavin ;

Comi, Giancarlo ;

Cook, Stuart ;

Rammohan, Kottil ;

Rieckmann, Peter ;

Sorensen, Per Soelberg ;

Vermersch, Patrick ;

Chang, Peter ;

Hamlett, Anthony ;

Musch, Bruno ;

Greenberg, Steven J. .

NEW ENGLAND JOURNAL OF MEDICINE, 2010, 362 (05) :416-426

[7] Treatment of early multiple sclerosis: the value of treatment initiation after a first clinical episode [J].

Goodin, D. S. ;

Bates, D. .

MULTIPLE SCLEROSIS, 2009, 15 (10) :1175-1182

[8] Safety profile of Tysabri: international risk management plan [J].

Iaffaldano, P. ;

D'Onghia, M. ;

Trojano, Maria .

NEUROLOGICAL SCIENCES, 2009, 30 :159-162

[9] A Placebo-Controlled Trial of Oral Fingolimod in Relapsing Multiple Sclerosis [J].

Kappos, Ludwig ;

Radue, Ernst-Wilhelm ;

O'Connor, Paul ;

Polman, Chris ;

Hohlfeld, Reinhard ;

Calabresi, Peter ;

Selmaj, Krzysztof ;

Agoropoulou, Catherine ;

Leyk, Malgorzata ;

Zhang-Auberson, Lixin ;

Burtin, Pascale .

NEW ENGLAND JOURNAL OF MEDICINE, 2010, 362 (05) :387-401

[10] Fingolimod and sphingosine-1-phosphate - Modifers of lymphocyte migration [J].

Massberg, Steffen ;

von Andrian, Ulrich H. .

NEW ENGLAND JOURNAL OF MEDICINE, 2006, 355 (11) :1088-1091

← 1 2 →